Do You Believe in Zoetis’ (ZTS) Long-Term Growth Potential?
Mairs & Power, an investment advisor, released the fourth-quarter 2025 investor letter for the “Mairs & Power Growth Fund.” A copy of the letter is available for download here.
Zoetis Inc. (ZTS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Zevenbergen Capital Investments Nancy Zevenbergen | 12,420 | $1,468,168 | -15% | 0.04% |
| 2. | Bourgeon Capital John Zaro | 1,871 | $221,171 | +1% | 0.04% |
| 3. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.48 | 2,100 | $347,508.00 | 7,590 | 2021-02-19 | Filing | |
| $164.89 | 2,900 | $478,181.00 | 5,490 | 2021-02-19 | Filing | |
| $163.80 | 2,590 | $424,242.00 | 2,590 | 2021-02-19 | Filing | |
| $74.56 | 10 | $745.60 | 17 | 2018-01-11 | Filing | |
| $50.31 | 7 | $352.17 | 7 | 2016-10-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $127.55 | 10,800 | $1,377,531.36 | 101,337 | 2026-02-17 | Filing | |
| $126.46 | 9,200 | $1,163,432.92 | 112,137 | 2026-02-17 | Filing | |
| $170.00 | 652 | $110,840.00 | 15,129 | 2025-06-03 | Filing | |
| $170.00 | 326 | $55,420.00 | 15,781 | 2025-03-10 | Filing | |
| $166.14 | 1,210 | $201,029.40 | 11,245 | 2025-03-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,820,022 | $215,144,801 | 1.52% | |
| 2. | 837,314 | $98,980,041 | 3.05% | |
| 3. | 491,051 | $58,047,139 | 1.7% | |
| 4. | 446,316 | $52,759,070 | 0.76% | |
| 5. | 358,560 | $42,385,378 | 0.9% |
News See All
Bristol Gate Capital Partners Sold Zoetis (ZTS) Due to Deteriorating Dividend Growth
Bristol Gate Capital Partners, an investment management company, published its Q4 2025 investor letter for the “US Equity Strategy”. A copy of the letter can be downloaded here.
What Makes Zoetis (ZTS) an Investment Bet?
Diamond Hill Capital, an investment management company, released its “Mid Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Is Zoetis Inc. (ZTS) A Good Stock To Buy Now?
Is ZTS a good stock to buy now? We came across a bullish thesis on Zoetis Inc. on Rebound Capital’s Substack. In this article, we will summarize the bulls’ thesis on ZTS.
Jensen Quality Growth Equity Strategy Decided to Sell Its Stake in Zoetis (ZTS)
Jensen Investment Management, an asset management company based in the US, released its fourth-quarter investor letter for “Jensen Quality Growth Equity Strategy”.
Barclays Remains a Hold on Zoetis Inc. (ZTS)
Zoetis Inc. (NYSE:ZTS) is one of the best pet stocks to buy according to hedge funds. Barclays reaffirmed a Hold rating on Zoetis Inc. (NYSE:ZTS) on February 18, setting a price target of $136.00.
10 Best Pet Stocks to Buy According to Hedge Funds
On February 12, Tom Lee of Fundstrat and Bitmine appeared on CNBC’s ‘Closing Bell’ to discuss the state of the markets and large themes moving stocks.
Zoetis (ZTS) Falls Following Q3 Disappointment and Librela Demand Weakness
Impax Asset Management's "Impax US Sustainable Economy Fund" released its Q4 2025 investor letter. A copy of the letter can be downloaded here.
Bank of America Cites Zoetis Inc.'s (ZTS) Strong Q4 Performance and Fiscal 2026 Outlook
TheFly reported on February 13 that Bank of America raised its price target for ZTS to $140 from $135 and maintained a Neutral rating on the shares. The upgraded target was supported by the company...
7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds
According to research, the U.S.
Hedge Fund Resource Center